Vital

When the medication isn't working

Zepbound Vial How Many Units: The 0.5 mL Draw Explained

How many units are in a Zepbound vial dose, what the single-dose vial Instructions for Use say about the 0.5 mL draw and the syringe, how the 0.6 mL multi-dose products differ, and common online errors.

Last reviewed

The Vital angle

In Vital, you can add tirzepatide and log each weekly dose with its strength and injection site, with a weekly reminder and a site suggestion. If you add the vial with its mg and 0.5 mL of liquid, the app shows the draw as 50 units and 0.5 mL on a U-100 syringe, and 1 dose per vial.

Zepbound vial: how many units

If you ask "Zepbound vial, how many units," the label answer is in mL, not units. Each Zepbound single-dose vial holds one dose in 0.5 mL, and the Instructions for Use say to draw to the 0.5 mL line and inject all of it. This is the same for every strength, from 2.5 mg/0.5 mL to 15 mg/0.5 mL. On a U-100 insulin syringe, where 1 unit is 0.01 mL, 0.5 mL lines up with the 50-unit mark.

The label does not use insulin units at all. It tells prescribers to have patients use a syringe that fits the dose, for example a 1 mL syringe that can measure 0.5 mL. So the safest answer is: draw 0.5 mL, the full dose in the vial, with the syringe your prescriber or pharmacist gave you. If your syringe is marked only in units, ask your pharmacist to confirm the 0.5 mL line before your first dose.

What is in each Zepbound vial

Zepbound (tirzepatide) is an FDA-approved medicine from Eli Lilly and Company for weight reduction and for obstructive sleep apnea in adults with obesity. The prescribing information lists these single-dose vials:

Vial strength Volume Draw on the Instructions for Use U-100 syringe mark for that volume
2.5 mg/0.5 mL 0.5 mL 0.5 mL 50 units
5 mg/0.5 mL 0.5 mL 0.5 mL 50 units
7.5 mg/0.5 mL 0.5 mL 0.5 mL 50 units
10 mg/0.5 mL 0.5 mL 0.5 mL 50 units
12.5 mg/0.5 mL 0.5 mL 0.5 mL 50 units
15 mg/0.5 mL 0.5 mL 0.5 mL 50 units

The draw is the same at every strength because each vial is made at a different concentration. A 2.5 mg vial is 5 mg/mL, and a 15 mg vial is 30 mg/mL. The dose changes with the vial you get, not with how much you draw. For that reason, the strength printed on the carton and the vial is the most important check each week.

How the Instructions for Use describe the draw

The single-dose vial Instructions for Use describe these main steps. Read the full leaflet in your carton, because it has pictures and details that this list leaves out.

  1. Check the vial label for the name and the strength, and check the expiration date.
  2. Wash your hands, and wipe the rubber stopper with an alcohol swab.
  3. Pull the plunger down to put 0.5 mL of air into the syringe, then push the air into the vial.
  4. Turn the vial upside down and pull the plunger past the 0.5 mL line.
  5. Tap out air bubbles, then slowly push the plunger up until the plunger tip reaches the 0.5 mL line.
  6. Inject under the skin of the stomach area or thigh. The leaflet says someone else can also inject in the back of the upper arm.
  7. Throw away the opened vial, even if medicine is left in it, and put the syringe in a sharps container.

The label says to always use a new syringe and needle for each injection. The carton does not include a syringe or needle. The LillyDirect page for the vial says a needle and syringe purchase is required, so ask your prescriber which syringe to buy.

Common online errors about Zepbound vials

Several claims that rank for this search are wrong or risky.

  • "2.5 mg is 25 units." This is wrong for the Zepbound vial. The 2.5 mg vial holds 2.5 mg in 0.5 mL, which is 50 units on a U-100 syringe. The "25 units" number comes from compounded vials at 10 mg/mL, which are a different product. See the tirzepatide units chart.
  • "Draw a different number of units for each strength." No. The label draw is 0.5 mL for every single-dose vial strength.
  • "Save the leftover for next week." The vial is single-dose, and the Instructions for Use say to throw it away after use, even if medicine is left. The CDC also says not to save leftover contents of single-dose vials.
  • "Split one vial into two doses." The label does not support this. Ask your prescriber if you need a different dose.
  • "The 0.6 mL line is right for vials." The 0.6 mL draw belongs to the multi-dose products. The single-dose vial is 0.5 mL.

Single-dose vial vs 0.6 mL multi-dose products

The current prescribing information lists two kinds of multi-dose containers: a single-patient-use KwikPen and a multi-dose vial. Each holds four weekly doses in 2.4 mL, at 0.6 mL per dose. The label lists them from 2.5 mg/0.6 mL to 15 mg/0.6 mL.

Product Volume per dose Doses per container Discard rule on the label
Single-dose vial 0.5 mL 1 After use, even if medicine is left
Multi-dose vial 0.6 mL 4 After 4 weekly doses, 30 days after first use, or 30 days total at room temperature, whichever comes first
KwikPen 0.6 mL dial 4 After 4 weekly doses, 30 days after first use, or 30 days total at room temperature, whichever comes first

On November 20, 2026, the LillyDirect page listed the single-dose vial, the single-dose pen, and the KwikPen. Read your carton to know which product you have. If the carton says "4 doses," the draw is 0.6 mL, not 0.5 mL. For refill planning with multi-dose containers, see how many doses in a vial.

Storage and missed doses from the label

The label says to keep single-dose vials in the refrigerator at 36°F to 46°F (2°C to 8°C). You may keep an unopened vial at room temperature up to 86°F (30°C) for a total of up to 21 days. Do not freeze it, and do not use it if it was frozen. Keep the vial in the carton to protect it from light. If a vial was left out, see GLP-1 left out of the fridge.

For a missed dose, the label says to take it as soon as possible within 4 days (96 hours). If more than 4 days have passed, skip it and take the next dose on the usual day. If you change your dose day, the label says to keep at least 3 days (72 hours) between two doses. See missed GLP-1 dose for more.

How Vital helps with a weekly vial

A vial routine has more steps than a pen: buy syringes, check the strength, draw, inject, and throw away. A log makes each week easier to check.

In Vital, you can add tirzepatide and log each weekly dose with the strength and the site. If you also want the draw on screen, add the vial with its mg and enter 0.5 mL as the liquid. Vital then shows 50 units and 0.5 mL as the draw for the full dose, and 1 dose per vial. You can set a weekly reminder and get a site suggestion, so you rotate between areas. See injection site rotation.

Vital is a tracking tool. It does not change your dose. Your prescriber sets the strength, and the Instructions for Use set the draw. For a view of weekly levels from the half-life, try the free GLP-1 level chart.

Warning signs that need care now

Get emergency care if you have:

  • Severe stomach pain that does not go away, with or without vomiting, which can be a sign of pancreatitis.
  • Pain in the upper right stomach, fever, or yellow skin or eyes, which can be gallbladder problems.
  • Swelling of the face, lips, tongue, or throat, or trouble breathing or swallowing.
  • Vomiting or diarrhea that stops you from keeping fluids down, which can cause dehydration and kidney problems.
  • A lump or swelling in the neck, hoarseness, or trouble swallowing.

If you think you injected more than one vial, call your prescriber or Poison Help at 1-800-222-1222. For other pen and vial problems, see Zepbound not working.


Zepbound®, KwikPen®, and LillyDirect® are trademarks of Eli Lilly and Company. Vital is independent and not affiliated with these companies.

Free toolGLP-1 medication level chart

Things to watch

Practical flags drawn from prescribing information and clinical guidance. Vital surfaces these in the dose log to help you spot them early.

  • "2.5 mg is 25 units" for Zepbound vials

    The Zepbound 2.5 mg vial holds 2.5 mg in 0.5 mL, which is 50 units on a U-100 syringe. The 25-unit figure is for a compounded vial at 10 mg/mL.

  • Saving leftover medicine

    The Instructions for Use say to throw away the opened single-dose vial, even if medicine is left. The CDC says not to save leftover contents of single-dose vials.

  • Splitting one vial into smaller doses

    The label supports one full 0.5 mL dose per single-dose vial. Ask your prescriber if you need a different strength.

  • The 0.6 mL line on a single-dose vial

    The 0.6 mL dose is for the 4-dose multi-dose vial and the KwikPen. The single-dose vial draw is 0.5 mL.

  • Reused syringes

    The label says to always use a new syringe and needle for each injection.

Frequently asked questions

  • The Instructions for Use say to draw 0.5 mL, the full vial. On a U-100 insulin syringe, 0.5 mL is the 50-unit mark. The label itself uses mL, so ask your pharmacist to confirm the line on your syringe.

  • No. Every single-dose vial, from 2.5 mg to 15 mg, holds one dose in 0.5 mL. The concentration changes with the strength, so the draw stays at 0.5 mL.

  • The label tells prescribers to have patients use a syringe that fits the dose, for example a 1 mL syringe that can measure 0.5 mL. The carton does not include a syringe. Use a new syringe and needle each time.

  • No. The Instructions for Use say to throw away the opened single-dose vial after use, even if medicine is left in it.

  • The 0.6 mL dose is for the multi-dose products, which hold 4 weekly doses in 2.4 mL. Read your carton: if it says 4 doses, follow the multi-dose Instructions for Use.

  • The label says you may store an unopened single-dose vial at room temperature up to 86°F (30°C) for a total of up to 21 days. Do not freeze it.

Sources

  1. Zepbound (tirzepatide) Prescribing Information and Instructions for Use · Eli Lilly and Company
  2. Authentic Zepbound (tirzepatide) Shipped to You · LillyDirect, Eli Lilly and Company
  3. Injection Safety: Clinical Safety Practices · Centers for Disease Control and Prevention
  4. FDA alerts health care providers, compounders and patients of dosing errors associated with compounded injectable semaglutide products · U.S. Food and Drug Administration

This page summarizes publicly available information from the sources listed above and is for educational use only. It is not medical advice. Consult a qualified healthcare professional for personal dosing guidance.

Track every shot, every change

Vital logs every GLP-1 injection and peptide dose, then surfaces patterns your scale can't show. Free on iOS and Android.